Oral cavity adjuvant therapy (OCAT) -a phase III, randomized controlled trial of surgery followed by conventional RT (5 fr/wk) versus concurrent CT-RT versus accelerated RT (6fr/wk) in locally advanced, resectable, squamous cell carcinoma of oral cavitySarbani Ghosh Laskar, D'Cruz Anil, Gouri Pantvaidya et al.|European Journal of Cancer|2022Cited by 29
The Promise of Magnetic Resonance Imaging in Radiation Oncology Practice in the Management of Brain, Prostate, and GI MalignanciesShashank Srinivasan, Vedang Murthy, Archya Dasgupta et al.|JCO Global Oncology|2022Cited by 26
Phase III randomized trial of surgery followed by conventional radiotherapy (5 fr/Wk) (Arm A) vs concurrent chemoradiotherapy (Arm B) vs accelerated radiotherapy (6fr/Wk) (Arm C) in locally advanced, stage III and IV, resectable, squamous cell carcinoma of oral cavity- oral cavity adjuvant therapy (OCAT): Final results (NCT00193843).Sarbani Ghosh Laskar, Anil D′Cruz, Devendra Chaukar et al.|Journal of Clinical Oncology|2016Cited by 21
Optimal timing of fluorine-18-fluoromisonidazole positron emission tomography/computed tomography for assessment of tumor hypoxia in patients with head and neck squamous cell carcinomaAbhishek Chatterjee, Jaiprakash Agarwal, Tejpal Gupta et al.|Nuclear Medicine Communications|2018Cited by 8
Evaluation of quantitative imaging parameters in head and neck squamous cell carcinomaTejpal Gupta, Jai P. AGARWAL, Abhishek Chatterjee et al.|The Quarterly Journal of Nuclear Medicine and Molecular Imaging|2022Cited by 6